Cite
HARVARD Citation
Felicetti, F. et al. (2017). Tyrosine kinase inhibitors rechallenge in solid tumors: a review of literature and a case description with lenvatinib in thyroid cancer. Expert review of anticancer therapy. 17 (12), pp. 1093-1098. [Online].